Himalaya Meditek Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 02-07-2024
- Paid Up Capital ₹ 2.36 Cr
as on 02-07-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.56 Cr
as on 02-07-2024
- Satisfied Charges ₹ 16.72 Cr
as on 02-07-2024
- Revenue 23.94%
(FY 2022)
- Profit 342.92%
(FY 2022)
- Ebitda 18.97%
(FY 2022)
- Net Worth 31.58%
(FY 2022)
- Total Assets 38.40%
(FY 2022)
About Himalaya Meditek
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.36 Cr.
The company currently has active open charges totaling ₹11.56 Cr. The company has closed loans amounting to ₹16.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Nandwani and Sanjay Nandwani serve as directors at the Company.
- CIN/LLPIN
U24230TG1999PTC031759
- Company No.
031759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Himalaya Meditek Private Limited offer?
Himalaya Meditek Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray, Paracetamol Tablets, Combiflam Tablet, Combiflam Pain Relief Spray, Cosmetics, Hair & Beauty Products, Skin Creams, Crocin Tablets.
Who are the key members and board of directors at Himalaya Meditek?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Nandwani  | Director | 01-Oct-2014 | Current |
| Sanjay Nandwani | Director | 01-Oct-2014 | Current |
Financial Performance and Corporate Structure Insights of Himalaya Meditek.
Himalaya Meditek Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.94% increase. The company also saw a substantial improvement in profitability, with a 342.92% increase in profit. The company's net worth Soared by an impressive increase of 31.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Himalaya Meditek?
In 2022, Himalaya Meditek had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saintlife Pharmaceuticals LimitedActive 8 years 4 monthsSunil Nandwani and Sanjay Nandwani are mutual person
- Saintlife Mediscience Private LimitedActive 9 years 9 months
Sunil Nandwani and Sanjay Nandwani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2022 | ₹6.56 Cr | Open |
Others Creation Date: 15 Dec 2016 | ₹5.00 Cr | Open |
Punjab National Bank Creation Date: 28 Mar 2013 | ₹3.10 Cr | Satisfied |
How Many Employees Work at Himalaya Meditek?
Himalaya Meditek has a workforce of 23 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Himalaya Meditek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himalaya Meditek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
